StockData
Oncolytics Biotech Inc logo

Oncolytics Biotech Inc (ONCY) stock

ONCYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 10-Q on Nov 13, 2026Score 0/30
$0.38+0.04 (+12.53%)

Close on Nov 17, 2026Market cap $48.77MP/E –Yield –

Oncolytics Biotech enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Oncolytics Biotech's enterprise value was $44.46M on Nov 11, 2026, against $68.36M a year earlier. Over the last 5 years it ranged from $15.61M to $142.06M, with a median of $56.73M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$44.46M-23.8%
2025Dec 31, 2025$58.31M+55.3%
2024Dec 31, 2024$37.55M-46.0%
2023Dec 29, 2023$69.50M+22.5%
2022Dec 30, 2022$56.73M+79.3%
2021Dec 31, 2021$31.64M-23.9%
2020Dec 31, 2020$41.59M-36.7%
2019Dec 31, 2019$65.67M+296.8%
2018Dec 31, 2018$16.55M-71.7%
2017Dec 29, 2017$58.49M+963.0%
2016Dec 30, 2016$5.50M–

More Oncolytics Biotech figures

See a number that looks wrong?